The Signal Journal
Back

Tag

us-markets

Trump Backs Warsh as Fed Eyes September Rate Hike

President Trump endorsed Fed Chair Kevin Warsh even as the two disagree on rate policy, after the Fed held rates steady but saw internal FOMC support for a hike. Financial markets are now pricing in a potential rate increase at the September Fed meeting.

Nasdaq Futures Drop 1.1% in Global Tech Sell-Off

Nasdaq futures dropped 1.1% on June 26, 2026, as a global technology sell-off resumed amid concerns over high valuations, production cuts, and rising volatility. S&P 500 futures also slid, pointing to a weak open for US markets with tech-heavy portfolios facing the sharpest pressure.

Nasdaq Recovers as Apple Drops on AI News

U.S. stocks closed mixed, with the Nasdaq posting a partial recovery while the Dow dipped lower. Apple fell after news about its AI plans unsettled investors, weighing on broader market sentiment.

Nasdaq Drops 4% as Fed Rate-Hike Bets Hammer AI Stocks

The Nasdaq dropped 4% on Wednesday as rising bets on Federal Reserve rate hikes hit AI and technology stocks hard. The S&P 500 and Dow Jones also fell, reflecting broad investor concern that borrowing costs could stay higher for longer.

S&P 500, Nasdaq Post Biggest Monthly Gains in Years

The S&P 500 and Nasdaq closed higher Thursday, booking their biggest monthly gains in years as strong corporate earnings offset oil and geopolitical concerns. Alphabet reported a record quarter for its cloud unit, boosting tech sentiment. Industrials and technology sectors led the broad-based rally.

Sun Pharma Buys U.S. Organon in $11.75 Billion Deal

Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.

The S&P 500 Rips to New All Time Highs

The S&P 500 has climbed to new all-time highs, marking a fresh peak for the broad U.S. equity benchmark. The move signals positive market sentiment and may influence allocation decisions across institutional and retail portfolios.

← Back

Tag

us-markets

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.

4mo ago · 1 min · Business

The S&P 500 Rips to New All Time Highs

The S&P 500 has climbed to new all-time highs, marking a fresh peak for the broad U.S. equity benchmark. The move signals positive market sentiment and may influence allocation decisions across institutional and retail portfolios.

4mo ago · 1 min · Markets

— End of feed —